“Np again mentioned deaths in the cd 12 trial ..
Post# of 148190
The phase 3 trial, like the phase 2 trial for M2M patients, is double blinded, which means the deaths being reported aren’t attributed to a specific arm. CYDY knows there have been deaths in the trial but can’t tell if they’re on the control or placebo arm. Yes, NP and CYDY believe most of these are deaths are in the placebo arm because of the EIND results, but we won’t know officially until the safety review and/or interim analysis.